These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 16580422

  • 1. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E, Ozdemir R, Barutcu I, Aksoy Y, Sincer I, Akturk E, Cehreli S.
    J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
    [Abstract] [Full Text] [Related]

  • 2. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 3. Heart rate variability and heart rate recovery in patients with coronary artery ectasia.
    Turker Y, Ozaydin M, Yucel H.
    Coron Artery Dis; 2010 Jan; 21(1):8-12. PubMed ID: 19838109
    [Abstract] [Full Text] [Related]

  • 4. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM.
    Int J Cardiol; 2007 Aug 09; 120(1):79-84. PubMed ID: 17134770
    [Abstract] [Full Text] [Related]

  • 5. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A.
    Am Heart J; 2003 Nov 09; 146(5):E18. PubMed ID: 14597947
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep 09; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 7. Impact of bariatric surgery--induced weight loss on heart rate variability.
    Nault I, Nadreau E, Paquet C, Brassard P, Marceau P, Marceau S, Biron S, Hould F, Lebel S, Richard D, Poirier P.
    Metabolism; 2007 Oct 09; 56(10):1425-30. PubMed ID: 17884456
    [Abstract] [Full Text] [Related]

  • 8. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
    Grabczewska Z, Białoszyński T, Szymański P, Sukiennik A, Swiatkiewicz I, Koziński M, Kochman W, Grześk G, Kubica J.
    Cardiol J; 2008 Oct 09; 15(4):344-50. PubMed ID: 18698543
    [Abstract] [Full Text] [Related]

  • 9. Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy.
    Pagkalos M, Koutlianos N, Kouidi E, Pagkalos E, Mandroukas K, Deligiannis A.
    Br J Sports Med; 2008 Jan 09; 42(1):47-54. PubMed ID: 17526623
    [Abstract] [Full Text] [Related]

  • 10. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F, Fragasso G, Rossetti E, Dabrowski P, Pagnotta P, Rosano GM, Chierchia SL.
    Cardiologia; 1999 Dec 09; 44(12):1065-9. PubMed ID: 10687257
    [Abstract] [Full Text] [Related]

  • 11. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 09; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 12. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
    Belardinelli R, Solenghi M, Volpe L, Purcaro A.
    Eur Heart J; 2007 May 09; 28(9):1102-8. PubMed ID: 17456483
    [Abstract] [Full Text] [Related]

  • 13. Effect of metoprolol on heart rate variability in symptomatic patients with mitral valve prolapse.
    Taçoy G, Balcioğlu AS, Arslan U, Durakoğlugil E, Erdem G, Ozdemir M, Cengel A.
    Am J Cardiol; 2007 Jun 01; 99(11):1568-70. PubMed ID: 17531582
    [Abstract] [Full Text] [Related]

  • 14. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr 01; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 15. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ, Raxwal VK, Roux L, Fearon WF, Froelicher VF.
    Am Heart J; 2001 Jul 01; 142(1):136-41. PubMed ID: 11431669
    [Abstract] [Full Text] [Related]

  • 16. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct 01; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 17. The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with coronary slow flow.
    Pekdemir H, Cicek D, Camsari A, Akkus MN, Cin VG, Doven O, Parmaksiz HT, Katircibasi MT, Ozcan IT.
    Ann Noninvasive Electrocardiol; 2004 Jan 01; 9(1):24-33. PubMed ID: 14731213
    [Abstract] [Full Text] [Related]

  • 18. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
    Eur Heart J; 2000 Sep 01; 21(18):1537-46. PubMed ID: 10973768
    [Abstract] [Full Text] [Related]

  • 19. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F.
    Int J Clin Pharmacol Ther; 1999 Jul 01; 37(7):347-51. PubMed ID: 10442509
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
    Fragasso G, Piatti PM, Monti L, Palloshi A, Lu C, Valsecchi G, Setola E, Calori G, Pozza G, Margonato A, Chierchia S.
    J Am Coll Cardiol; 2002 Feb 06; 39(3):413-9. PubMed ID: 11823078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.